News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biohit’s Colonview Validation For Colorectal Cancer Screening Program In Brazil


12/20/2013 9:45:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Barretos Cancer Hospital (BCH) in Brazil starts a clinical study validating Biohit’s ColonView compared as one of the two potential alternatives for the colorectal cancer (CRC) screening program decided to start at BCH in 2015. In contrast to the comparison test, ColonView is rapid test specific for detecting human blood in the stools, derived from CRC and its precursors. Validation of the test in a clinical setting is the necessary first step before consideration for inclusion in a population-based screening program.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
Biohit
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES